UiPath에 대한 매도 수량은 투자자에게 UiPath의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

UiPath (NYSE:PATH) 주식, 공매도 수량 보고

UiPath

UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

Analyst Color

Long Ideas

Sector ETFs

Analyst Ratings

Tech

Trading Ideas

ETFs

ABBNY

ISRG

NVDA

PATH

PLTR

ZBRA

미국의 경쟁력은 2025년에 네 가지 주요 투자 테마인 에너지 독립, 방산 혁신, 인프라 및 자동화가 포트폴리오 성장을 강화할 태세를 갖추면서 중심 무대로 떠오른다. 스콧 헬프스타인(Scott Helfstein)이 이끄는 글로벌 X의 2025년 투자 전망은 이러한 변혁적인 트렌드를 향후 1년 동안의 회복력의 중요한 동력으로 강조하고 있다.

2025 투자 테마: 인공지능, 에너지 및 방산이 미국 시장을 재정의

Earnings

News

After-Hours Center

Movers

유아이패스(NYSE:PATH)는 목요일(5일) 장 마감 후 3분기 실적을 발표했다. 이번 실적 보고서의 자세한 내용을 확인해 보자.

유아이패스: 3분기 실적 예상치 상회했지만 시간외 7% 하락

Broad U.S. Equity ETFs

Education

Specialty ETFs

ADPT

ARKG

ARKK

CDNA

COIN

CRSP

HOOD

IONS

NRIX

NTRA

RBLX

ROKU

RXRX

SHOP

TSLA

TWST

VYCT

캐시 우드가 이끄는 아크 펀드(Ark Funds)는 미래 성장 혁신 분야에 중점을 두고 적극적으로 관리되는 ETF들 덕분에 가장 잘 알려진 펀드 매니저 중 하나이다. 이 펀드의 ETF 두 개가 목요일에 10주년을 맞이했다. 이들 펀드의 출시와 지난 10년 동안의 성과를 살펴보겠다.

캐시 우드의 아크 이노베이션, 지노믹스 ETF가 10주년을 기념: 연간 수익률을 S&amp;P 500과 비교

UiPath Inc

Pathfinder Bancorp Inc

PATHFINDER CELL THERAPY by Pathfinder Cell Therapy, Inc.

Pathfinder Cell Therapy Inc

Pathfinder Ventures Inc

PATHFINDER VENTURES INC by PATHFINDER VENTURES INC.

Pathward Financial Inc

Needham analyst Scott Berg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) from Hold to Hold.

Reiteration

Needham Reiterates Hold on UiPathto Hold

WIIM

ADBE

ADSK

AGYS

APPN

ASAN

BILL

BTCS

BTDR

BTOG

CDNS

CLSK

CRWD

CWAN

CYBR

DDOG

DOCU

DSGX

ESTC

ETWO

EVCM

EXFY

FICO

FRSH

FTNT

GREE

GRYP

HTCR

HUBS

INTU

KVYO

LMFA

LSPD

MANH

MAWSON INFRSTRUCTURE GRP by Mawson Infrastructure Group Inc.

MIGI

MSFT

NCTY

NICE

NTNX

PANW

PCOR

PRCH

RAMP

RBRK

SDIG

SNPS

TEAM

TRAK

TZUP

UPLD

Shares of stocks in the broader software sector are trading lower amid overall market weakness following the Fed's rate decision to cut rates by 25 basis points.

UBS analyst Jeff Hickey initiates coverage on UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Sell rating and announces Price Target of $14.

Price Target

Initiation

UBS Initiates Coverage On UiPath with Sell Rating, Announces Price Target of $14

U.S. competitiveness takes center stage in 2025 with four key investment themes—energy independence, defense innovation, infrastructure, and automation—poised to bolster portfolio growth. Global X's 2025 Investment Outlook, led by Scott Helfstein, highlights these transformative trends as critical drivers of resilience <a href="https://www.benzinga.com/topic/us-economy">in the coming year.</a>
<h2 class="wp-block-heading">Infrastructure Gets A Glow-Up</h2>
America&#8217;s infrastructure renaissance is going full throttle, with $700 billion in spending set to energize construction, equipment, and materials companies. This may bode well for investors in the Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>).
These stalwarts of the old economy are reinventing themselves with cutting-edge tech to expand margins—all while trading at attractive valuations compared to the broader S&amp;P 500.
<h2 class="wp-block-heading">The Defense Play: Beyond Jets &amp; Ships</h2>
Global tensions are driving a pivot from traditional defense platforms to high-tech solutions like AI-driven drones and cybersecurity systems. 
Palantir Technologies Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) Artificial Intelligence Platform and International Business Machines Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBM#NYSE">IBM</a>) WatsonX AI come to mind here.
Defense revenues are expected to jump nearly 10%, with margins climbing from 5.2% to 7.6%. Success will favor those adopting automation and next-generation technologies in this competitive landscape.
Read Also: <a href="https://www.benzinga.com/news/small-cap/24/12/42438879/manufacturing-tariffs-small-cap-could-steal-the-show-in-2025">Manufacturing Comeback? Strategist Expects Tariffs To Help Small-Cap Stocks But Weigh On Consumers</a>
<h2 class="wp-block-heading">Automation &amp; Onshoring: A Tech Revolution</h2>
With the U.S. accelerating its onshoring efforts, automation and AI are emerging as the driving forces powering the shift.
Software companies and data centers are prepping for a revenue surge, with mega-cap tech upping its spending on data centers to $250 billion in 2025. 
Robotics and IoT hardware could also rebound from a sales plateau, making the automation sector one to watch. Companies enabling robotics and automation such as Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>), ABB (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ABBNY#OTC">ABBNY</a>), Rockwell Automation&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ROK#NYSE">ROK</a>), Zebra Technologies&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBRA#NASDAQ">ZBRA</a>), Teradyne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TER#NASDAQ">TER</a>) and UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) come to mind.
<h2 class="wp-block-heading">Energy Independence Goes Nuclear</h2>
Energy's next frontier? Nuclear. With mega-cap tech giants eyeing modular nuclear reactors as a green and reliable power source, demand for uranium is heating up. Beyond the U.S., countries like Japan and Germany are also jumping on the nuclear bandwagon, signaling a global shift toward energy resilience.
U.S. companies such as Constellation Energy&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEG#NASDAQ">CEG</a>), Cameco&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCJ#NYSE">CCJ</a>) and NuScale Power&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) come to mind.
Helfstein's roadmap suggests a year of targeted strategies. By aligning portfolios with these U.S.-centric themes, investors might not just weather volatility—they could thrive in the chaos.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/24/12/42437267/berkshire-palantir-etfs-add-high-octane-trading-options-with-direxions-launch">Berkshire, Palantir ETFs Add High-Octane Trading Options With Direxion&#8217;s Launch</a></li>
</ul>
Photo: Shutterstock

2025 Investment Themes: AI, Energy, Defense Redefine US Markets

Barclays analyst Raimo Lenschow maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and raises the price target from $15 to $16.

Barclays Maintains Equal-Weight on UiPath, Raises Price Target to $16

Morgan Stanley analyst Keith Weiss maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Equal-Weight and raises the price target from $15 to $16.

Morgan Stanley Maintains Equal-Weight on UiPath, Raises Price Target to $16

UiPath Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) analysts stay mostly on the sidelines with concerns for the short-term after the company reported third-quarter financial results Thursday.
The PATH Analysts: Oppenheimer analyst Brian Schwartz maintained a Perform rating on UiPath with no price target.
RBC Capital Markets analyst Matthew Hedberg maintained a Sector Perform rating with a $16 price target.
Truist analyst Terry Tillman maintained a Hold rating with a $14 price target.
KeyBanc Capital Markets analyst Jason Celino maintained a Sector Weight rating with no price target.
JPMorgan analyst Mark Murphy maintained an Overweight rating and raised the price target from $17 to $18.
Oppenheimer on PATH: Management commentary could suggest that stabilization is expected for the company next year, Schwartz said in a new investor note.
The analyst said margin growth returning and guidance for faster free cash flow growth are positives from the quarter. The negatives were soft guidance, modest billings growth and declining net new ARR (annual recurring revenue) trends, the analyst added.
"F3Q results and guidance are unlikely to alleviate investor concerns that AI is weakening the company's moat," Schwartz said.
RBC Capital on PATH: The quarterly results showed improved execution and a stable demand environment Hedberg said in a new investor note.
The analyst highlighted the company's commentary on stabilized net new ARR in the report.
"We continue to believe PATH is likely to remain range-bound over the medium term and as execution improvement plays out and the agent vision unfolds," Hedberg said.
Hedberg highlighted UiPath's commentary on early interest from customers with over 1,000 sign-ups for the Agent Builder product.
"While we like the agent vision and improved execution, we think it will take some time to see tangible benefits from agentic solutions, and we'd like to see more proof points of stability in results."
Truist on PATH: The company's growth remains sluggish going forward, Tillman said in a new investor note.
"The story remains a work in progress in terms of improving annualized renewal run-rate and returning net new ARR to a position of solid growth," Tillman said.
The analyst said the company showed progress in the third quarter with advancing partnerships and early adoption of its agentic automation.
"Sustained execution improvement remain key to growth reacceleration, in our opinion."
KeyBanc on PATH: Initial fiscal 2026 commentary was more mixed than expected, Celino said in a new investor note.
The analyst said the commentary that net new ARR dollars are expected to stabilize could be viewed as a downtick versus consensus estimates of a modest uptick.
"In terms of macro, UiPath noted trends remain largely consistent with no noticeable signs of improvements or deterioration," Celino said.
Celino said there could be long-term opportunities, but the near-term execution and growth challenges remain near-term concerns.
JPMorgan on PATH: The company showed a positive tone with its outlook and commentary, Murphy said in a new investor note.
The analyst said the company's Second Act is centered on the Agentic Model.
"UiPath appears to be making bold moves and speaking very confidently to its Agentic vision, conveying an ability to up-level conversations with customers and elevating its platform beyond just automation," Murphy said.
The new platform could open up the company for "new growth vectors," the analyst said.
"Overall, we view the performance in the quarter as solid, and see the business as mostly stable/stabilizing."
PATH Price Action: UiPath stock is down 2.47% to $14.58 on Friday versus a 52-week trading range of $10.37 to $27.87. The stock is down 39% year-to-date in 2024.
Read Next: • <a href="https://www.benzinga.com/economics/macro-economic-events/24/12/42363278/us-economy-adds-227000-jobs-in-november-wage-growth-accelerates">US Economy Adds 227,000 Jobs In November, Wage Growth Accelerates</a>
Photo: Courtesy of UiPath, Inc.

Guidance

UiPath 'Story Remains A Work In Progress': Analysts Want To See More After Q3 Results, 'Sustained Execution Remains Key'

BMO Capital analyst Keith Bachman maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Market Perform and raises the price target from $15 to $16.

BMO Capital Maintains Market Perform on UiPath, Raises Price Target to $16

RBC Capital analyst Matthew Hedberg reiterates UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Sector Perform and maintains $16 price target.

RBC Capital Reiterates Sector Perform on UiPath, Maintains $16 Price Target

JP Morgan analyst Mark Murphy maintains UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) with a Overweight and raises the price target from $17 to $18.

JP Morgan Maintains Overweight on UiPath, Raises Price Target to $18

U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Friday.
Shares of Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/insights/earnings/24/12/42351795/smith-wesson-brands-q2-earnings-insights">second-quarter results</a>.
The company posted net sales of $129.7 million, an increase of 3.8%, over the year-ago period and 46.8%, over the previous quarter.
Smith &amp; Wesson Brands shares dipped 15.8% to $11.48 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Oriental Rise Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORIS#NASDAQ">ORIS</a>) shares tumbled 81.2%</li>
<li> to $10.50 in pre-market trading after surging 599% on Thursday.</li>
<li>zSpace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZSPC#NASDAQ">ZSPC</a>) declined 31.7% to $15.01 in pre-market trading after jumping 340% on Thursday.</li>
<li>Samsara Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) shares tumbled 10.6% to $49.29 in pre-market trading following third-quarter results.</li>
<li>8&#215;8, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGHT#NASDAQ">EGHT</a>) fell 6.2% to $2.87 in pre-market trading.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) dipped 4.1% to $14.34 in pre-market trading following third-quarter results.</li>
<li>Douglas Dynamics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) fell 4% to $24.31 in pre-market trading.</li>
<li>Movado Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) dropped 3.3% to $20.11 in pre-market trading. The company, on Thursday, reported third-quarter results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42357598/dow-dips-more-than-200-points-ahead-of-jobs-report-investor-sentiment-declines-fear-greed-index-remains-in-greed-zone">Dow Takes A Breather After Record Close, Dips Over 200 Points Ahead Of Jobs Report: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Pre-Market Outlook

Markets

EGHT

ORIS

PLOW

SWBI

ZSPC

Smith & Wesson Brands, Samsara, UiPath And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Analysts' ratings for UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) over the last quarter vary from bullish to bearish, as provided by 2 analysts.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated UiPath and provided 12-month price targets. The average target is $15.0, accompanied by a high estimate of $17.00 and a low estimate of $13.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 11.76%. 
<img src="https://www.benzinga.com/files/images/story/2024/1733490188_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of UiPath among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Murphy</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$17.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to UiPath. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of UiPath compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of UiPath's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into UiPath's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PATH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on UiPath analyst ratings.</a>
<h2>About UiPath</h2>
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
<h3>Unraveling the Financial Story of UiPath</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: UiPath's remarkable performance in 3 months is evident. As of 31 July, 2024, the company achieved an impressive revenue growth rate of 10.07%. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: UiPath's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -27.22%, the company may face hurdles in effective cost management.
Return on Equity (ROE): UiPath's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -4.46%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): UiPath's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -3.1%, the company may face hurdles in achieving optimal financial returns.
Debt Management: UiPath's debt-to-equity ratio is below the industry average at 0.05, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Scoreboard: 2 Ratings For UiPath

UiPath, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) reported its third-quarter results after Thursday's closing bell. Here's a look at the details <a href="https://www.benzinga.com/pressreleases/24/12/b42351006/uipath-reports-third-quarter-fiscal-2025-financial-results">from the report. </a>
The Details: UiPath reported quarterly earnings of 11 cents per share, which beat the analyst consensus estimate of seven cents. Quarterly revenue came in at $354.65 million which beat the analyst consensus estimate of $347.69 million and is an increase over sales of $325.92 million from the same period last year.
UiPath reported: 
<ul>
<li>ARR of $1.607 billion, increased 17% year-over-year.</li>
<li>Net new ARR of $56 million.</li>
<li>Dollar-based net retention rate of 113%.</li>
<li>Non-GAAP gross margin was 85%.</li>
<li>Non-GAAP operating income was $50 million.</li>
<li>Net cash flow from operations was $28 million.</li>
<li>Non-GAAP adjusted free cash flow was $33 million. </li>
</ul>
Read Next: <a href="https://www.benzinga.com/24/12/42316904/unitedhealthcare-ceo-brian-thompson-dies-after-being-shot-outside-nyc-hotel">UnitedHealthcare CEO Brian Thompson Fatally Shot Outside NYC Hotel</a>
&#8220;Our customers&#8217; response to the agentic automation vision and roadmap that we announced at FORWARD has been energizing and reinforces our leading position in the AI-powered automation market,&#8221; said Daniel Dines, UiPath CEO. 
&#8220;We have conviction that UiPath provides a differentiated approach to agentic automation that will expand our market opportunity by enabling customers to automate more complex and variable workflows to deliver enterprise-wide AI transformation,&#8221; Dines added.
Outlook: UIPath sees fourth-quarter revenue in a range of $422 million to $427 million, versus the $423.79 million estimate. 
PATH Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, UiPath shares are down 2.14% after-hours at $14.63 at the time of publication Thursday. 
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/24/12/42300548/art-cashins-lessons-cuban-crisis-trades-to-timeless-wall-street-wit">Art Cashin&#8217;s Lessons: Cuban Crisis Trades To Timeless Wall Street Wit</a></li>
</ul>
Photo: Courtesy of UiPath, Inc.

UiPath Shares Wobble After Q3 Results: EPS Beat, Revenue Beat

UIPath Sees Q4 2025 Revenue $422M-$427M Vs $423.79M Est.

UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) reported quarterly earnings of $0.11 per share which beat the analyst consensus estimate of $0.07 by 57.14 percent. The company reported quarterly sales of $354.65 million which beat the analyst consensus estimate of $347.69 million by 2.00 percent. This is a 8.82 percent increase over sales of $325.92 million the same period last year.

Earnings Beats

UiPath Q3 2025 Adj EPS $0.11 Beats $0.07 Estimate, Sales $354.65M Beat $347.69M Estimate

UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) reported its Q3 earnings results on Thursday, December 5, 2024 at 04:10 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
UiPath beat estimated earnings by 56.99999999999999%, reporting an EPS of $0.11 versus an estimate of $0.07.
Revenue was up $28.73 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company beat on EPS by $0.01 which was followed by a 6.0% drop in the share price the next day.
Here's a look at UiPath's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.03</td>
<td>0.12</td>
<td>0.16</td>
<td>0.07</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.04</td>
<td>0.13</td>
<td>0.22</td>
<td>0.12</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>303.67M</td>
<td>333.04M</td>
<td>383.83M</td>
<td>315.55M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>316.25M</td>
<td>335.11M</td>
<td>405.25M</td>
<td>325.92M</td>
</tr>
</tbody>
</table>

To track all earnings releases for UiPath <a href="https://www.benzinga.com/quote/PATH/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Recap: UiPath Q3 Earnings

<h3>Companies Reporting Before The Bell</h3>
• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLY#NYSE">WLY</a>) is likely to report quarterly earnings at $0.70 per share on revenue of $420.00 million. 
• America's Car-Mart (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRMT#NASDAQ">CRMT</a>) is projected to report quarterly loss at $0.10 per share on revenue of $344.37 million. 
• Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) is expected to report quarterly earnings at $2.16 per share on revenue of $1.93 billion. 
• Patterson Cos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDCO#NASDAQ">PDCO</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.65 billion. 
• Methode Electronics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEI#NYSE">MEI</a>) is estimated to report quarterly loss at $0.16 per share on revenue of $268.46 million. 
• Signet Jewelers (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIG#NYSE">SIG</a>) is projected to report quarterly earnings at $0.33 per share on revenue of $1.37 billion. 
• Dollar Gen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DG#NYSE">DG</a>) is estimated to report quarterly earnings at $0.94 per share on revenue of $10.14 billion. 
• Korn Ferry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KFY#NYSE">KFY</a>) is projected to report quarterly earnings at $1.21 per share on revenue of $675.35 million. 
• Movado Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) is likely to report quarterly earnings at $0.00 per share on revenue of $187.70 million. 
• Lands' End (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LE#NASDAQ">LE</a>) is likely to report quarterly earnings at $0.03 per share on revenue of $315.21 million. 
• Hooker Furnishings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOFT#NASDAQ">HOFT</a>) is projected to report quarterly earnings at $0.28 per share on revenue of $101.35 million. 
• Toronto-Dominion Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TD#NYSE">TD</a>) is likely to report quarterly earnings at $1.28 per share on revenue of $10.26 billion. 
• GMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) is projected to report quarterly earnings at $2.19 per share on revenue of $1.46 billion. 
• Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) is expected to report quarterly loss at $0.12 per share on revenue of $1.71 billion. 
• Duluth Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DLTH#NASDAQ">DLTH</a>) is expected to report quarterly loss at $0.32 per share on revenue of $134.93 million. 
• Kroger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) is projected to report quarterly earnings at $0.98 per share on revenue of $34.20 billion. 
• Canadian Imperial Bank (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CM#NYSE">CM</a>) is likely to report quarterly earnings at $1.26 per share on revenue of $4.67 billion. 
• Caleres (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAL#NYSE">CAL</a>) is estimated to report quarterly earnings at $1.36 per share on revenue of $751.36 million. 
• Bank of Montreal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMO#NYSE">BMO</a>) is likely to report quarterly earnings at $1.73 per share on revenue of $5.98 billion. 
• Brown Forman Inc Class B Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $1.07 billion. 
• John Wiley &amp; Sons (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLYB#NYSE">WLYB</a>) is expected to report earnings for its second quarter. 
• Build-A-Bear Workshop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBW#NYSE">BBW</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $113.40 million. 
• Tuniu (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOUR#NASDAQ">TOUR</a>) is likely to report earnings for its third quarter. 
• Brown Forman Inc Class A Common Stock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BF#NYSE">BF</a>) is projected to report earnings for its second quarter. 
<h3>Companies Reporting After The Bell</h3>
• Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $253.96 million. 
• Victoria's Secret (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VSCO#NYSE">VSCO</a>) is likely to report quarterly loss at $0.62 per share on revenue of $1.29 billion. 
• UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) is likely to report quarterly earnings at $0.07 per share on revenue of $347.72 million. 
• Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $133.52 million. 
• Asana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) is expected to report quarterly loss at $0.07 per share on revenue of $180.66 million. 
• Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) is projected to report quarterly earnings at $0.03 per share on revenue of $222.04 million. 
• Domo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOMO#NASDAQ">DOMO</a>) is estimated to report quarterly loss at $0.15 per share on revenue of $77.55 million. 
• Lakeland Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAKE#NASDAQ">LAKE</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $44.30 million. 
• Argan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGX#NYSE">AGX</a>) is estimated to report quarterly earnings at $1.26 per share on revenue of $225.60 million. 
• Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) is expected to report quarterly earnings at $2.72 per share on revenue of $2.36 billion. 
• Veeva Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>) is likely to report quarterly earnings at $1.58 per share on revenue of $684.34 million. 
• Smartsheet (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMAR#NYSE">SMAR</a>) is likely to report quarterly earnings at $0.30 per share on revenue of $283.87 million. 
• GitLab (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTLB#NASDAQ">GTLB</a>) is likely to report quarterly earnings at $0.16 per share on revenue of $188.25 million. 
• HashiCorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCP#NASDAQ">HCP</a>) is likely to report quarterly earnings at $0.05 per share on revenue of $163.39 million. 
• Tilly's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLYS#NYSE">TLYS</a>) is likely to report quarterly loss at $0.32 per share on revenue of $140.84 million. 
• Ulta Beauty (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) is projected to report quarterly earnings at $4.52 per share on revenue of $2.50 billion. 
• Rubrik (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBRK#NYSE">RBRK</a>) is likely to report quarterly loss at $0.40 per share on revenue of $217.53 million. 
• Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) is projected to report quarterly loss at $0.03 per share on revenue of $1.50 billion. 
• Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $310.56 million. 
• DocuSign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) is expected to report quarterly earnings at $0.87 per share on revenue of $745.26 million. 
• American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) is projected to report quarterly earnings at $0.20 per share on revenue of $53.23 million. 
• Hewlett Packard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPE#NYSE">HPE</a>) is likely to report quarterly earnings at $0.56 per share on revenue of $8.26 billion. 
• Cooper Companies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COO#NASDAQ">COO</a>) is likely to report quarterly earnings at $1.00 per share on revenue of $1.03 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AOUT

CRMT

CSIQ

DLTH

DOMO

GTLB

GWRE

HOFT

LAKE

LULU

PDCO

SAIC

SMAR

TLYS

TOUR

ULTA

VEEV

VSCO

WLYB

WOOF

ZUMZ

Earnings Scheduled For December 5, 2024

ADEA

BRZE

BTBT

CFLT

CIFR

MNDY

MSTR

NVNI

ORCL

QUBT

RIOT

SOUN

WDAY

WULF

Shares of stocks in the broader software sector are trading higher. Some names may be moving following better-than-expected earnings from Salesforce and Okta.

U.S. stocks were higher, with the Dow Jones index gaining more than 150 points on Wednesday.
Shares of Pure Storage Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) gained 26.1% to $67.48 after the company reported better-than-expected third-quarter financial results and issued fourth-quarter <a href="https://www.benzinga.com/news/earnings/24/12/42303442/pure-storage-shares-soar-after-strong-q3-q4-guidance-above-estimates-details">guidance above estimates</a>.
Pure Storage reported quarterly earnings of 50 cents per share, which beat the analyst consensus estimate of 42 cents. Quarterly revenue came in at $831.07 million which beat the consensus estimate of $818.14 million and is an increase over sales of $762.84 million from the same period last year.
Pure Storage shares jumped 26.1% to $67.48 on Wednesday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Cross Country Healthcare, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCRN#NASDAQ">CCRN</a>) shares gained 61.9% to $18.07 after Aya Healthcare announced a definitive agreement to acquire the company for approximately $615 million.</li>
<li>Altimmune Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) surged 22.4% to $10.76.</li>
<li>Marvell Technology Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) climbed 22% to $117.05 as the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance above estimates on Tuesday.</li>
<li>Hesai Group – ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) gained 20.6% to $9.65.</li>
<li>Stoke Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STOK#NASDAQ">STOK</a>) jumped 15.2% to $13.17 after the company announced it received breakthrough therapy designation status from the FDA for Zorevuvnersen.</li>
<li>Navitas Semiconductor Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) rose 15.1% to $3.6150.</li>
<li>Bitdeer Technologies Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>) climbed 14.6% to $16.97.</li>
<li>MaxLinear, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MXL#NASDAQ">MXL</a>) gained 14.2% to $19.85.</li>
<li>Microvast Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVST#NASDAQ">MVST</a>) gained 14.2% to $1.61.</li>
<li>Zeta Global Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NASDAQ">ZETA</a>) rose 13.3% to $27.10 after the company announced a 106% year-over-year usage increase for its marketing platform from Thanksgiving to Cyber Monday.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) gained 12.4% to $9.99.</li>
<li>Roku, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) rose 10.2% to $83.41. Needham maintained a Buy rating on the stock.</li>
<li>Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) gained 9.2% to $362.05 following third-quarter results.</li>
<li>Powell Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POWL#NASDAQ">POWL</a>) surged 8.8% to $292.50.</li>
<li>UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) rose 8.5% to $15.61.</li>
<li>JetBlue Airways Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) gained 7.2% to $6.49.</li>
<li>MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) rose 6.6% to $345.27 after Baird maintained an Outperform rating on the stock and raised its price target from $305 to $380.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42314096/att-to-rally-around-14-here-are-10-top-analyst-forecasts-for-wednesday">AT&amp;T To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday</a></li>
</ul>

Intraday Update

CCRN

HSAI

JBLU

MRVL

MVST

NVTS

POWL

PSTG

STOK

ZETA

Pure Storage Posts Upbeat Results, Joins Cross Country Healthcare, Marvell Technology, Stoke Therapeutics And Other Big Stocks Moving Higher On Wednesday

UBS initiated coverage of UiPath (PATH) with a Sell rating and $14 price target UBS sees an increasingly competitive backdrop against large tech in...

UiPath initiated with a Sell at UBS

Comments

UiPath

매도 수량

UiPath (NYSE:PATH) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌